Previous 10 | Next 10 |
Collaboration provides phase-appropriate plasmid DNA to support the development of engineered stem cells for cancer therapy Charles River Laboratories International, Inc. (NYSE: CRL) and National University of Singapore’s (NUS) Yong Loo Lin School of Medicine (NUS Medicin...
2024-03-15 22:14:17 ET Summary Ariel Investments' 13F portfolio value increased from $9.45B to $10.04B in Q4 2023. The largest five stakes in the portfolio are Jones Lang LaSalle, Mattel, Generac Holdings, Carlyle Group, and Charles River Laboratories. Stake increases were see...
2024-03-14 10:27:07 ET More on Charles River Laboratories Charles River Laboratories: Weak Biopharma Spending Is Transitory; Initiate With 'Hold' Charles River Laboratories International, Inc. (CRL) Q4 2023 Earnings Call Transcript DURECT and Charles River enter agre...
Next-generation AAV gene therapy to target debilitating pain disorders Charles River Laboratories International, Inc. (NYSE: CRL) and Navega Therapeutics , Inc., a biotechnology company developing epigenetic gene therapies, today announced an AAV9 production program agreement. As pa...
2024-03-09 11:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-07 12:27:11 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Stock markets are reaching new highs and exuberance is in the air. For value investors, this might seem like a perplexing time. However, there are still bargains to be found… outside...
2024-03-07 06:55:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bitcoin ( BTC-USD ) hit a record high of $69,202, topping its previous high of $68,999.99 in November 2021. That’s good news for Coinbase Global (NASDAQ: COIN ...
Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-in-Human Use PR Newswire WILMINGTON, Mass. and OKLAHOMA CITY , Feb. 29, 2024 /PRNewswire/ -- Wheeler Bio, Inc., an agile contr...
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a strategic agreement with Wheeler Bio, Inc., an antibody contract development and manufacturing organization (CDMO) focused on preclinical and early clinical supply of recombinant proteins, providing clients access to Whe...
The addition of ES cells and iPSCs will enhance Charles River’s portfolio of powerful research tools supporting acceleration of therapeutic development. Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into an agreement with Plurist...
News, Short Squeeze, Breakout and More Instantly...
Charles River Laboratories International Inc. Company Name:
CRL Stock Symbol:
NYSE Market:
Lentiviral vector CDMO collaboration to support advanced cell therapies for hematological cancers Charles River Laboratories International, Inc. (NYSE: CRL) and the Gates Institute at the University of Colorado Anschutz Medical Campus today announced a lentiviral vector contract...
2024-06-18 18:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Leveraging CGT CDMO expertise to support T-cell immunotherapy clinical trial Charles River Laboratories International, Inc. (NYSE: CRL) and Captain T Cell, a spinoff from the renowned Max Delbrück Center Berlin, Germany, today announced a plasmid DNA and retrovirus vector productio...